TP53 and cancer: Pathway analyses and gene set enrichment analyses demonstrated alterations in many cancer-related hallmark pathways, such as the downregulation of NFkB signaling, KRAS signaling, inflammatory responses, hypoxia, estrogen response and UV response, and upregulation of p53 signaling, among others (Fig. 6C).